InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
79.75
(
0.00%
)
Bitcoin
67,974.30
(
0.25%
)
Post# of 4764
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: None

Wednesday, 02/14/2007 9:36:05 PM

Wednesday, February 14, 2007 9:36:05 PM

Post# of 4764
Article on generic biologics

http://biz.yahoo.com/ap/070214/generic_biotech_drugs.html?.v=1

I found the following quote interesting.

"It is not as though approval of follow-on biologics will be a huge paradigm shift," said Amgen Vice President David Beier. "Mainly because there are frequently already second generation versions of biological products on the market that offer superior patient value in terms of safety, convenience and efficacy."

Because its new, It must be good.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up